Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2026-03-26 @ 1:46 AM
Study NCT ID:
NCT06026332
Status:
RECRUITING
Last Update Posted:
2025-09-17
First Post:
2023-08-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
Sponsor:
Ferring Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
000431
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None